Hims & Hers Health, Inc.

Informe acción NYSE:HIMS

Capitalización de mercado: US$3.4b

Hims & Hers Health Crecimiento futuro

Future controles de criterios 6/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Hims & Hers Health de 38.1% y 22.2% por año respectivamente. Se prevé que el BPA crezca en un 35.2% al año. Se espera que la rentabilidad financiera sea de 33.8% en 3 años.

Información clave

40.9%

Tasa de crecimiento de los beneficios

37.7%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare19.4%
Tasa de crecimiento de los ingresos22.6%
Rentabilidad financiera futura25.1%
Cobertura de analistas

Good

Última actualización12 Aug 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Hims & Hers: Digesting Q2 2024 Earnings, Shares Still Undervalued, Rating Downgrade

Aug 20

Hims & Hers Health, Inc.'s (NYSE:HIMS) Share Price Is Still Matching Investor Opinion Despite 27% Slump

Aug 11
Hims & Hers Health, Inc.'s (NYSE:HIMS) Share Price Is Still Matching Investor Opinion Despite 27% Slump

Hims & Hers Health: Buy The Dip, With Or Without The GLP-1 Shortage

Aug 07

Hims & Hers: The Thesis Goes Far Beyond GLP-1

Jul 18

Hims & Hers: Buy The Dip To Catch The Next Rip

Jun 24

Why Investors Shouldn't Be Surprised By Hims & Hers Health, Inc.'s (NYSE:HIMS) 70% Share Price Surge

Jun 19
Why Investors Shouldn't Be Surprised By Hims & Hers Health, Inc.'s (NYSE:HIMS) 70% Share Price Surge

Hims & Hers: The Undervalued Gem Poised For Growth

Jun 18

Beyond The Marketing Machine: Why Hims & Hers Stock Might Be Vulnerable

Jun 10

Hims & Hers Health, Inc.'s (NYSE:HIMS) CEO Compensation Is Looking A Bit Stretched At The Moment

May 31
Hims & Hers Health, Inc.'s (NYSE:HIMS) CEO Compensation Is Looking A Bit Stretched At The Moment

Hims & Hers: Soaring On Access To Compounded GLP-1 Drugs, Further Volatility Ahead

May 21

Hims & Hers Health: An Unforced Error

May 06

Hims & Hers Health, Inc. (NYSE:HIMS) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing

May 04
Hims & Hers Health, Inc. (NYSE:HIMS) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing

Hims & Hers Health: Becoming A Market Leader Within The Growing Digital Health Industry

Apr 24

Hims & Hers Health: Strong Prospects But Weak Business Model Consolidation

Apr 05

Hims & Hers: 5 Reasons Why This Is A Phenomenal Long-Term Growth Stock

Mar 21

Pills Pay The Bills: Mini Deep Dive On Hims & Hers Health

Mar 12

Investors Appear Satisfied With Hims & Hers Health, Inc.'s (NYSE:HIMS) Prospects As Shares Rocket 49%

Feb 28
Investors Appear Satisfied With Hims & Hers Health, Inc.'s (NYSE:HIMS) Prospects As Shares Rocket 49%

Hims & Hers: Turning The Profitability Corner And Returning 28%

Feb 25

Hims & Hers Health: No Clear Moat Besides First Mover Advantage

Jan 23

Hims & Hers Health: Unleashing Macro Momentum - Investing In Growth At A Higher Multiple

Jan 10

Investors Still Waiting For A Pull Back In Hims & Hers Health, Inc. (NYSE:HIMS)

Jan 07
Investors Still Waiting For A Pull Back In Hims & Hers Health, Inc. (NYSE:HIMS)

Hims & Hers Health Q3: The Cheapest Growth Stock Around

Dec 14

Hims & Hers Health: What Would The Author Of 100 Baggers Say?

Nov 30

Hims & Hers: The Most Undervalued Small Cap Stock I See

Nov 08

Hims & Hers: A Promising Company With Resolvable Challenges

Nov 02

Hims & Hers: Specialization Is The Secret To Great Growth

Oct 25

Hims & Hers Health: Can't Get Much Better

Sep 25

The Market Is Wrong On Hims & Hers Health

Sep 18

Hims & Hers: The Current Weakness Creates A Buying Opportunity

Aug 15

Hims & Hers Health: Giving Investors Another Bite At The Apple

Aug 01

Hims & Hers Health, Inc.'s (NYSE:HIMS) Price In Tune With Revenues

Jul 21
Hims & Hers Health, Inc.'s (NYSE:HIMS) Price In Tune With Revenues

Hims & Hers Health: Expect Strong EBITDA Growth As Revenue Growth Remains Strong

Jul 13

Hims & Hers Health: Double-Edged Sword

Jul 02

Hims & Hers: More Transparency Could Help The Stock

Jun 09

Previsiones de crecimiento de beneficios e ingresos

NYSE:HIMS - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
12/31/20262,25613422034311
12/31/20251,8919818124313
12/31/20241,389499919413
6/30/20241,0671890127N/A
3/31/2024959-25290N/A
12/31/2023872-244773N/A
9/30/2023793-362745N/A
6/30/2023711-471226N/A
3/31/2023616-59-62N/A
12/31/2022527-66-34-27N/A
9/30/2022444-86-29-23N/A
6/30/2022374-83-51-45N/A
3/31/2022321-73-43-38N/A
12/31/2021272-108-39-34N/A
9/30/2021229-82-36-32N/A
6/30/2021196-72-17-12N/A
3/31/2021171-63-18-13N/A
12/31/2020149-18-7-2N/A
9/30/2020132-25-16-13N/A
6/30/2020112-38-43-41N/A
3/31/202095-58-62-60N/A
12/31/201983-72-77-75N/A
12/31/201827-75-57-57N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (38.1% al año) de HIMS es superior a la tasa de ahorro (2.5%).

Beneficios vs. Mercado: Se prevé que los beneficios (38.1% al año) de HIMS crezcan más rápidamente que el mercado US (14.9% al año).

Beneficios de alto crecimiento: Se espera que los beneficios de HIMS crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (18.4% al año) de HIMS crezcan más rápidamente que los del mercado US (8.7% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos (22.2% al año) de HIMS crezcan más rápidamente que un 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de HIMS sea alta dentro de 3 años (33.8%)

Descubre empresas en crecimiento

7D

1Y

7D

1Y

7D

1Y